24h購物| | PChome| 登入
2009-07-05 00:22:48| 人氣884| 回應0 | 上一篇 | 下一篇

[Tour de France] 阿姆斯壯將面臨很仔細的藥檢

推薦 0 收藏 0 轉貼0 訂閱站台




法國的運動部長Roselyne Bachelot保證今年的環法賽會嚴格執行藥檢,並告訴阿姆斯壯(環法賽七連霸的美籍選手):「你會被特別地、特別地、特別地注意!」雖然幾次身陷使用禁藥的爭議,阿姆斯壯優秀的醫療團隊與律師都讓他全身而退。然而在歐洲,就有運動報直指阿姆斯壯使用禁藥並說謊,阿姆斯壯大牌行徑與排場在歐洲也很不得人緣。因此,你應該就可以理解,法國的運動部長何以會連用三個「特別地」來叮囑這位被老美捧上天的英雄、生命鬥士、慈善家。對於這一則報導,我想倫敦泰晤士報應該不至於加油添醋才是。


July 3, 2009
Lance Armstrong faces close scrutiny during Tour de France

The French Sports Minister has told Lance Armstrong that he will be "particularly monitored" in anti-doping checks at the Tour de France this year.

Roselyne Bachelot has promised stringent testing during this year's race, and singled out the seven-times Tour winner. "The [doping] controls will be multiplied, and I tell Lance Armstrong that he will be particularly, particularly, particularly monitored," Bachelot said.

The American, who has come out of retirement to race again in cycling's showcase, has denied ever having taken banned substances during his cycling career.

The head of France's anti-doping agency, which with the International Cycling Union is planning more than 500 doping checks during this year's race, has previously said Armstrong will be treated like any other rider regarding drug testing.


(Tony Gentile/Reuters)

Lance Armstrong crosses the finish line at the end of the last stage of the Giro d'Italia

"There needs to be a really very, very active fight against doping," Bachelot said. "The organizers know how much a positive doping test could have harmful effects." The three-week race starts tomorrow in Monaco.

http://www.timesonline.co.uk/tol/sport/more_sport/cycling/article6629317.ece



The story was taken from TimesOnline at above-stated URL.  The copyright remains with its original owners.  The Times is not involved with, nor endorse the production of this blog.

台長: frank
人氣(884) | 回應(0)| 推薦 (0)| 收藏 (0)| 轉寄
全站分類: 運動體育(各種運動、運動情報、球迷會) | 個人分類: 單車紀事 |
此分類下一篇:[Tour de France] 認識自由車環法賽
此分類上一篇:[Cycling] 自由車的三大賽事

是 (若未登入"個人新聞台帳號"則看不到回覆唷!)
* 請輸入識別碼:
請輸入圖片中算式的結果(可能為0) 
(有*為必填)
TOP
詳全文